| scholarly article | Q13442814 |
| P50 | author | Paul Zarogoulidis | Q91514619 |
| Konstantinos Zarogoulidis | Q118869745 | ||
| Ioannis Kioumis | Q118907166 | ||
| Sofia Lampaki | Q118907468 | ||
| Konstantinos Porpodis | Q124157336 | ||
| P2093 | author name string | Lonny Yarmus | |
| Marek Malecki | |||
| Raf Malecki | |||
| Maria Mavroudi | |||
| P2860 | cites work | Embryonic stem cell differentiation: emergence of a new era in biology and medicine | Q22065783 |
| Modulation of T-cell activation by malignant melanoma initiating cells | Q24595394 | ||
| Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population | Q24634572 | ||
| Totipotency, pluripotency and nuclear reprogramming | Q24646675 | ||
| Stem cells and targeted approaches to melanoma cure | Q26825014 | ||
| Pancreatic cancer stem cells: emerging target for designing novel therapy | Q26863365 | ||
| ROS1 rearrangements define a unique molecular class of lung cancers | Q27851700 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| How do chemotherapeutic agents damage the ovary? | Q28267696 | ||
| A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models | Q39630653 | ||
| Protecting against wayward human induced pluripotent stem cells with a suicide gene | Q39660981 | ||
| Activation of caspase-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene/ganciclovir (HSV-tk/GCV) system | Q39965192 | ||
| Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. | Q39999949 | ||
| Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase | Q40171701 | ||
| Distribution and in situ proliferation patterns of intravenously injected immortalized human neural stem-like cells in rats with focal cerebral ischemia | Q40487319 | ||
| SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells | Q42092920 | ||
| Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes | Q42959429 | ||
| Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy | Q43100976 | ||
| Transdifferentiation by defined factors as a powerful research tool to address basic biological questions | Q43129946 | ||
| Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. | Q43871288 | ||
| Selective ablation of human embryonic stem cells expressing a "suicide" gene | Q44438602 | ||
| Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario | Q44763875 | ||
| Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications | Q44993714 | ||
| Repairing cartilage defects with bone marrow mesenchymal stem cells induced by CDMP and TGF-β1. | Q45358477 | ||
| Spermine-alt-poly(ethylene glycol) polyspermine as a safe and efficient aerosol gene carrier for lung cancer therapy | Q45855846 | ||
| Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures | Q45857108 | ||
| Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. | Q45980241 | ||
| Roadblocks en route to the clinical application of induced pluripotent stem cells | Q46054370 | ||
| Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy | Q46549703 | ||
| Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia | Q46721125 | ||
| Neural stem cell-based dual suicide gene delivery for metastatic brain tumors | Q48360437 | ||
| Stem cell gene expression programs influence clinical outcome in human leukemia. | Q51856192 | ||
| Reprogramming, transdifferentiation and the shifting landscape of cellular identity. | Q53248969 | ||
| Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. | Q54271815 | ||
| Isolation of single, intact chromosomes from single, selected ovarian cancer cells for in situ hybridization and sequencing. | Q54334800 | ||
| [New drugs and targeted therapeutic agents in ovarian cancer]. | Q54709050 | ||
| c-Met is a marker of pancreatic cancer stem cells and therapeutic target | Q84816959 | ||
| Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer | Q28274188 | ||
| Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen | Q28283278 | ||
| Identification of pancreatic cancer stem cells | Q28286997 | ||
| Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation | Q28383334 | ||
| Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed eukaryotic translation initiation factor 5A | Q28568517 | ||
| Cisplatin: mode of cytotoxic action and molecular basis of resistance | Q29615385 | ||
| A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog | Q33509682 | ||
| The bioethics of stem cell research and therapy | Q33559689 | ||
| Doxorubicin-induced ovarian toxicity | Q33729075 | ||
| Dexamethasone treatment induces the reprogramming of pancreatic acinar cells to hepatocytes and ductal cells. | Q33737536 | ||
| A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer | Q33786353 | ||
| Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration | Q33909634 | ||
| Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Plurip | Q33920686 | ||
| Induced pluripotent stem cells in medicine and biology | Q34036938 | ||
| Advances in mesenchymal stem cell-mediated gene therapy for cancer. | Q34135233 | ||
| Direct reprogramming of mouse fibroblasts to neural progenitors | Q34180572 | ||
| Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma | Q34208293 | ||
| Stem cells as therapeutic vehicles for the treatment of high-grade gliomas | Q34240433 | ||
| Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming | Q34273843 | ||
| Sox2 promotes tamoxifen resistance in breast cancer cells | Q34381786 | ||
| Antitumor activities of human placenta-derived mesenchymal stem cells expressing endostatin on ovarian cancer | Q34387403 | ||
| The effects of radiotherapy and chemotherapy on female reproduction | Q34452333 | ||
| Stem cells--a clinical update. | Q34565718 | ||
| Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells | Q34569068 | ||
| PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2 | Q34577769 | ||
| Reprogramming of human fibroblasts toward a cardiac fate | Q34619852 | ||
| In vitro and in vivo effect of 5-FC combined gene therapy with TNF-α and CD suicide gene on human laryngeal carcinoma cell line Hep-2. | Q34674653 | ||
| Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes | Q34998939 | ||
| Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy | Q35029953 | ||
| Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer | Q35109273 | ||
| Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise | Q35254797 | ||
| Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. | Q35561650 | ||
| Mesenchymal stem cells: clinical applications and biological characterization. | Q35686355 | ||
| Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management | Q35868495 | ||
| Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue | Q38094379 | ||
| Biology and clinical applications of pancreatic cancer stem cells | Q38102108 | ||
| New issues in systemic therapy for ovarian cancer | Q38109140 | ||
| Application of stem cells in targeted therapy of breast cancer: a systematic review | Q38117203 | ||
| Clinical applications of mesenchymal stem cells | Q38122364 | ||
| Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer | Q38125505 | ||
| Biological delivery approaches for gene therapy: strategies to potentiate efficacy and enhance specificity | Q38126261 | ||
| Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review | Q38162444 | ||
| Conversion of mouse and human fibroblasts into functional spinal motor neurons | Q38651033 | ||
| Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from A549 cells through down-regulation of pAkt | Q39061722 | ||
| Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth. | Q39137011 | ||
| Neural stem cell-based gene therapy for brain tumors | Q39137284 | ||
| Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis | Q39270339 | ||
| Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer | Q39310184 | ||
| Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody | Q39441685 | ||
| Cytotoxic antibody fragments for eliminating undifferentiated human embryonic stem cells | Q39565944 | ||
| Advancing stem cell biology toward stem cell therapeutics | Q39588798 | ||
| Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. | Q35921537 | ||
| Targeted cancer therapy--are the days of systemic chemotherapy numbered? | Q36174805 | ||
| Possible direct cytoxicity effects of cyclophosphamide on cultured human follicles: an electron microscopy study | Q36271406 | ||
| Stem cells: classifications, controversies, and clinical applications | Q36304941 | ||
| An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells | Q36510839 | ||
| Frontiers in Suicide Gene Therapy of Cancer | Q36534930 | ||
| Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. | Q36625210 | ||
| Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review). | Q36640056 | ||
| Tooth regeneration in operative dentistry | Q36677110 | ||
| Therapeutic potential of mesenchymal stem cells in regenerative medicine | Q36737833 | ||
| Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies | Q36796375 | ||
| Systemic cancer therapy: achievements and challenges that lie ahead | Q36821958 | ||
| Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells. | Q36934047 | ||
| Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells | Q37192753 | ||
| Direct transdifferentiation of spermatogonial stem cells to morphological, phenotypic and functional hepatocyte-like cells via the ERK1/2 and Smad2/3 signaling pathways and the inactivation of cyclin A, cyclin B and cyclin E | Q37360201 | ||
| The current knowledge on radiosensitivity of ovarian follicle development stages. | Q37371374 | ||
| Resistance to endocrine therapy: are breast cancer stem cells the culprits? | Q37404590 | ||
| Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? | Q37615286 | ||
| How far are induced pluripotent stem cells from the clinic? | Q37723608 | ||
| Stem cells as vectors for antitumour therapy | Q37730300 | ||
| Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation | Q37771132 | ||
| Teratomas from pluripotent stem cells: A clinical hurdle | Q37776212 | ||
| Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging | Q37794511 | ||
| Toxicity of chemotherapy and radiation on female reproduction | Q37806907 | ||
| The tumorigenicity of human embryonic and induced pluripotent stem cells | Q37851350 | ||
| Assessing the safety of stem cell therapeutics | Q37882177 | ||
| Stem cell based cancer gene therapy | Q37901007 | ||
| Fertility sparing in cancer patients | Q37932564 | ||
| Novel approaches to the treatment of acute myeloid leukemia | Q37967249 | ||
| Fertility preservation in women after the cancer | Q37974274 | ||
| Pluripotent stem cell-based cancer therapy: promise and challenges | Q37998452 | ||
| Acute myelogenous leukemia stem cells: from Bench to Bedside. | Q38020081 | ||
| Stem cell based glioblastoma gene therapy | Q38031961 | ||
| Female fertility loss and preservation: threats and opportunities | Q38057986 | ||
| Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. | Q38062772 | ||
| Fertility preservation in pediatric, adolescent and young adult female cancer patients. | Q38087335 | ||
| P433 | issue | 1 | |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 22-33 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Journal of cancer research & therapy | Q27725483 |
| P1476 | title | Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy | |
| P478 | volume | 2 |
| Q33826992 | 'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis |
| Q42181493 | A gene therapy induced emphysema model and the protective role of stem cells |
| Q35654976 | DDMC-p53 gene therapy with or without cisplatin and microwave ablation |
| Q37289486 | Lithium chloride has a biphasic effect on prostate cancer stem cells and a proportional effect on midkine levels |
| Q34462056 | Suicide genes: monitoring cells in patients with a safety switch |
| Q88213483 | [Importance of the tumor stem cell hypothesis for understanding ovarian cancer] |
Search more.